We are pleased to present below all posts archived in 'January, 2017'. If you still can't find what you are looking for, try using the search box.
Biofortuna is expanding its IVD service portfolio to provide a greater focus on immunoassay design, development and manufacture. The company has made a significant investment in its production capabilities to include plate coating, washing, drying and quality control, creating an exceptional manufacturing suite for immunoassay kits.
Read the rest of entry »
Mologic is pleased to announce that we are in receipt of a grant from the Bill & Melinda Gates Foundation to establish the CARD, a new technology centre within Mologic, whose objective is to create a step-change in simple, rapid diagnostic test technology for the detection of protein biomarkers at the point-of care.
Who are the BIVDA Members
Member Press Releases
Point of Care Directory
News, Policy and Media
BIVDA Press Releases